Park I - Search Results

1

Angiopoietin-1 suppresses choroidal neovascularization and vascular leakage.

Lee J, Park DY, Park DY, Park I, Chang W, Nakaoka Y, Komuro I, Yoo OJ, Koh GY. Lee J, et al. Among authors: park i, park dy. Invest Ophthalmol Vis Sci. 2014 Apr 7;55(4):2191-9. doi: 10.1167/iovs.14-13897. Invest Ophthalmol Vis Sci. 2014. PMID: 24609620

2

A Designed Angiopoietin-1 Variant, Dimeric CMP-Ang1 Activates Tie2 and Stimulates Angiogenesis and Vascular Stabilization in N-glycan Dependent Manner.

Oh N, Kim K, Kim SJ, Park I, Lee JE, Seo YS, An HJ, Kim HM, Koh GY. Oh N, et al. Among authors: park i. Sci Rep. 2015 Oct 19;5:15291. doi: 10.1038/srep15291. Sci Rep. 2015. PMID: 26478188 Free PMC article.

3

Angiopoietin-2 exacerbates cardiac hypoxia and inflammation after myocardial infarction.

Lee SJ, Lee CK, Kang S, Park I, Kim YH, Kim SK, Hong SP, Bae H, He Y, Kubota Y, Koh GY. Lee SJ, et al. Among authors: park i. J Clin Invest. 2018 Nov 1;128(11):5018-5033. doi: 10.1172/JCI99659. Epub 2018 Oct 8. J Clin Invest. 2018. PMID: 30295643 Free PMC article.

4

Tie2 activation promotes choriocapillary regeneration for alleviating neovascular age-related macular degeneration.

Kim J, Park JR, Choi J, Park I, Hwang Y, Bae H, Kim Y, Choi W, Yang JM, Han S, Chung TY, Kim P, Kubota Y, Augustin HG, Oh WY, Koh GY. Kim J, et al. Among authors: park i, park jr. Sci Adv. 2019 Feb 13;5(2):eaau6732. doi: 10.1126/sciadv.aau6732. eCollection 2019 Feb. Sci Adv. 2019. PMID: 30788433 Free PMC article.

5

Vascular RhoJ is an effective and selective target for tumor angiogenesis and vascular disruption.

Kim C, Yang H, Fukushima Y, Saw PE, Lee J, Park JS, Park I, Jung J, Kataoka H, Lee D, Heo WD, Kim I, Jon S, Adams RH, Nishikawa S, Uemura A, Koh GY. Kim C, et al. Among authors: park js, park i. Cancer Cell. 2014 Jan 13;25(1):102-17. doi: 10.1016/j.ccr.2013.12.010. Cancer Cell. 2014. PMID: 24434213 Free article.

6

Perilipin+ embryonic preadipocytes actively proliferate along growing vasculatures for adipose expansion.

Hong KY, Bae H, Park I, Park DY, Kim KH, Kubota Y, Cho ES, Kim H, Adams RH, Yoo OJ, Koh GY. Hong KY, et al. Among authors: park i, park dy. Development. 2015 Aug 1;142(15):2623-32. doi: 10.1242/dev.125336. Development. 2015. PMID: 26243869

7

VEGF-Grab Enhances the Efficacy of Radiation Therapy by Blocking VEGF-A and Treatment-Induced PlGF.

Park I, Yang H, Park JS, Koh GY, Choi EK. Park I, et al. Among authors: park js. Int J Radiat Oncol Biol Phys. 2018 Nov 1;102(3):609-618. doi: 10.1016/j.ijrobp.2018.06.401. Epub 2018 Jul 11. Int J Radiat Oncol Biol Phys. 2018. PMID: 30017791

8

Morphological Analysis of Lacteal Structure in the Small Intestine of Adult Mice.

Suh SH, Hong SP, Park I, Song JH, Koh GY. Suh SH, et al. Among authors: park i. Methods Mol Biol. 2018;1846:131-139. doi: 10.1007/978-1-4939-8712-2_8. Methods Mol Biol. 2018. PMID: 30242756

9

Novel glycosylated VEGF decoy receptor fusion protein, VEGF-Grab, efficiently suppresses tumor angiogenesis and progression.

Lee JE, Kim C, Yang H, Park I, Oh N, Hua S, Jeong H, An HJ, Kim SC, Lee GM, Koh GY, Kim HM. Lee JE, et al. Among authors: park i. Mol Cancer Ther. 2015 Feb;14(2):470-9. doi: 10.1158/1535-7163.MCT-14-0968-T. Epub 2014 Dec 22. Mol Cancer Ther. 2015. PMID: 25534360

10

VEGFR2 but not VEGFR3 governs integrity and remodeling of thyroid angiofollicular unit in normal state and during goitrogenesis.

Jang JY, Choi SY, Park I, Park DY, Choe K, Kim P, Kim YK, Lee BJ, Hirashima M, Kubota Y, Park JW, Cheng SY, Nagy A, Park YJ, Alitalo K, Shong M, Koh GY. Jang JY, et al. Among authors: park yj, park jw, park i, park dy. EMBO Mol Med. 2017 Jun;9(6):750-769. doi: 10.15252/emmm.201607341. EMBO Mol Med. 2017. PMID: 28438786 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

5,882 results

Search Page